Myovant Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MYOV and buy or sell other stocks, ETFs, and their options commission-free!

About MYOV

Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. 

CEO
David C. Marek
CEODavid C. Marek
Employees
Employees
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2016
Founded2016
Employees
Employees

MYOV Key Statistics

Market cap
2.62B
Market cap2.62B
Price-Earnings ratio
-14.05
Price-Earnings ratio-14.05
Dividend yield
Dividend yield
Average volume
1.68M
Average volume1.68M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$27.06
52 Week high$27.06
52 Week low
$7.67
52 Week low$7.67

Stock Snapshot

With a market cap of 2.62B, Myovant Sciences(MYOV) trades at $26.98. The stock has a price-to-earnings ratio of -14.05.

During the trading day, Myovant Sciences(MYOV) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.68M.

Over the past 52 weeks, Myovant Sciences(MYOV) stock has traded between a high of $27.06 and a low of $7.67.

Over the past 52 weeks, Myovant Sciences(MYOV) stock has traded between a high of $27.06 and a low of $7.67.

People also own

Based on the portfolios of people who own MYOV. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.